{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:48:43Z","timestamp":1761569323046,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900700"],"award-info":[{"award-number":["81900700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clgc.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T23:32:08Z","timestamp":1600385528000},"page":"e156-e165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Jianyong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinda","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2020.09.004_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 Update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819844483","article-title":"A\u00a0comparison of different prophylactic intravesical chemotherapy regimens for bladder cancer recurrence after nephroureterectomy for primary upper tract urothelial carcinomas: a retrospective 2-center study","volume":"18","author":"Huang","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.clgc.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/iju.13054","article-title":"Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"23","author":"Yamashita","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A\u00a0systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.09.004_bib7","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1515\/cclm-2015-1191","article-title":"Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection","volume":"54","author":"Wang","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clgc.2020.09.004_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00345-016-1864-9","article-title":"Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients","volume":"35","author":"Hu","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/SLA.0000000000002660","article-title":"The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study","volume":"270","author":"Aziz","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.clgc.2020.09.004_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s10120-019-01027-6","article-title":"The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy","volume":"23","author":"Li","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.clgc.2020.09.004_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/CMAR.S186976","article-title":"Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis","volume":"11","author":"Chen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clgc.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","article-title":"Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)","volume":"8","author":"Mandaliya","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.clgc.2020.09.004_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","article-title":"Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients","volume":"36","author":"Mihai Dorin","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s10147-017-1150-x","article-title":"A\u00a0critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma","volume":"22","author":"Mesut","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bju.12441","article-title":"Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma","volume":"114","author":"Dalpiaz","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.09.004_bib16","first-page":"348","article-title":"Preoperative low lymphocyte-to-monocyte ratio predicts poor clinical outcomes for patients with urothelial carcinoma of the upper urinary tract","volume":"15","author":"Zhang","year":"2018","journal-title":"Urol J"},{"key":"10.1016\/j.clgc.2020.09.004_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1245\/s10434-018-6942-3","article-title":"Combination of the preoperative systemic immune-inflammation index and monocyte-lymphocyte ratio as a novel prognostic factor in patients with upper-tract urothelial carcinoma","volume":"26","author":"Jan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib18","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/s41598-019-42781-y","article-title":"The evaluation of monocyte lymphocyte ratio as a preoperative predictor in urothelial malignancies: a pooled analysis based on comparative studies","volume":"9","author":"Zhu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clgc.2020.09.004_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2019.02.007","article-title":"Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma","volume":"492","author":"Li","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clgc.2020.09.004_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10147-018-01381-y","article-title":"Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy","volume":"24","author":"Itami","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000452109","article-title":"Validation of the preoperative platelet-to-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma","volume":"98","author":"Dalpiaz","year":"2017","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2020.09.004_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12935-019-1032-6","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis","volume":"19","author":"Bao","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clgc.2020.09.004_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10147-016-1040-7","article-title":"The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy","volume":"22","author":"Kishimoto","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib24","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.clgc.2019.09.017","article-title":"Preoperative pyuria predicts for intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy without a history of bladder cancer","volume":"18","author":"Sato","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.09.004_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijsu.2019.03.022","article-title":"Clinicopathological and prognostic significance of preoperative plasma fibrinogen level in patients with upper urinary tract urothelial carcinoma: a retrospective tumor marker prognostic study","volume":"65","author":"Liu","year":"2019","journal-title":"Int J Surg"},{"key":"10.1016\/j.clgc.2020.09.004_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/jclinpath-2014-202658","article-title":"Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma","volume":"68","author":"Hutterer","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clgc.2020.09.004_bib27","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/OTT.S97520","article-title":"Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy","volume":"9","author":"Song","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clgc.2020.09.004_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s10147-017-1150-x","article-title":"A\u00a0critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma","volume":"22","author":"Altan","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2020.09.004_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","article-title":"The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer","volume":"265","author":"Chan","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.clgc.2020.09.004_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2020.09.004_bib32","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"Movahedi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2020.09.004_bib33","doi-asserted-by":"crossref","first-page":"6058147","DOI":"10.1155\/2016\/6058147","article-title":"Tumor-associated macrophages and neutrophils in tumor microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clgc.2020.09.004_bib34","doi-asserted-by":"crossref","first-page":"e1093277","DOI":"10.1080\/2162402X.2015.1093277","article-title":"Small cell lung cancer: recruitment of macrophages by circulating tumor cells","volume":"5","author":"Hamilton","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clgc.2020.09.004_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.smim.2016.03.018","article-title":"Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells","volume":"28","author":"Moses","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.clgc.2020.09.004_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","article-title":"Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location","volume":"98","author":"Zigeuner","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.09.004_bib37","doi-asserted-by":"crossref","first-page":"59.e9","DOI":"10.1016\/j.urolonc.2015.08.015","article-title":"Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"34","author":"Otsuka","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jso.20459","article-title":"Bladder recurrence of upper urinary tract cancer after laparoscopic surgery","volume":"93","author":"Kume","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.09.004_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.urolonc.2014.04.006","article-title":"Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration","volume":"32","author":"Fradet","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2020.09.004_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","article-title":"Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance","volume":"29","author":"Azemar","year":"2011","journal-title":"Urol Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320302202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320302202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:34:22Z","timestamp":1761564862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767320302202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1558767320302202"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2020.09.004","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}